BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23323004)

  • 1. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy.
    Ang J; Hu L; Huang PT; Wu JX; Huang LN; Cao CH; Zheng YX; Chen L
    World J Gastroenterol; 2012 Dec; 18(47):7026-32. PubMed ID: 23323004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy.
    Gao X; Zhang Y; Yuan F; Ding B; Ma Q; Yang W; Yan J; Du L; Wang B; Yan F; Sedlmair M; Pan Z; Zhang H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2207-2218. PubMed ID: 30094537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of double contrast-enhanced ultrasound QontraXt three-dimensional pseudocolor quantitative analysis to therapeutic effect evaluation of preoperative neoadjuvant chemotherapy in advanced gastric cancer patients].
    Yan CX; Huang PT; Shentu WH; Lin ZM; Li J; Zhang Y; Xu JH; Jin XL
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):857-863. PubMed ID: 30481939
    [No Abstract]   [Full Text] [Related]  

  • 6. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
    Liu K; Li G; Fan C; Zhou C; Li J
    Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions.
    Shi H; Yu XH; Guo XZ; Guo Y; Zhang H; Qian B; Wei ZR; Li L; Wang XC; Kong ZX
    World J Gastroenterol; 2012 Aug; 18(31):4136-44. PubMed ID: 22919245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0.
    Odawara S; Kitajima K; Katsuura T; Kurahashi Y; Shinohara H; Yamakado K
    Eur J Radiol; 2018 Apr; 101():65-71. PubMed ID: 29571803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.
    Sun Z; Cheng X; Ge Y; Shao L; Xuan Y; Yan G
    Gastric Cancer; 2018 May; 21(3):413-420. PubMed ID: 28871423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.
    Lundsgaard Hansen M; Fallentin E; Lauridsen C; Law I; Federspiel B; Bæksgaard L; Svendsen LB; Nielsen MB
    PLoS One; 2014; 9(5):e97605. PubMed ID: 24845062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the diagnostic performance of response evaluation criteria in solid tumor 1.0 with response evaluation criteria in solid tumor 1.1 on MRI in advanced breast cancer response evaluation to neoadjuvant chemotherapy.
    Jeh SK; Kim SH; Kang BJ
    Korean J Radiol; 2013; 14(1):13-20. PubMed ID: 23323026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S; von Gall C; Stange A; Haag GM; Weitz J; Haberkorn U; Lordick F; Weichert W; Abel U; Debus J; Jäger D; Münter MW
    BMC Cancer; 2011 Jun; 11():266. PubMed ID: 21702914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
    Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
    J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Wei C; He Y; Luo M; Chen G; Nie R; Chen X; Zhou Z; Chen Y
    BMC Cancer; 2023 Nov; 23(1):1157. PubMed ID: 38012547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of dual-energy CT-based volumetric iodine-uptake in the evaluation of chemotherapy efficacy in advanced gastric cancer].
    Chen LF; Fu GZ; Huang DP; Man Y; Jin Y; Dong QT; Huang YB; Chen YC; Wang HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):977-983. PubMed ID: 31630497
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
    JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.